Subtype
Intermediate (Locally Aggressive) Blood Vessel Neoplasm
CI-CAN-00005579Explore in graph →
Non-malignant1 active trials
- NCIt
- C45473
Loading cancer entity…
Subtype
CI-CAN-00005579Explore in graph →
Clinical trials
5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03188068 | Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | completed | Phase 2 | 30 | West China HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Apr 21, 2022source: clinicaltrials